Am J Transplant, Volume 20, Suppl 3 Archives - Page 205 of 223 - ATC Abstracts

2020 American Transplant Congress
Comparison of 1-Year Incidence of De Novo Donor Specific Antibodies between Thymoglobulin and Alemtuzumab Induction in Kidney Transplantation
J. P. Knorr, C. Kallis, D. A. Portley, A. Jeyarajasingam, P. W. Lai, G. Bradauskaite, K. Khanmoradi
Transplant Nephrology, Einstein Medical Center, Philadelphia, PA
*Purpose: Development of de novo donor specific antibodies (dnDSA) after kidney transplantation (KTx) has been associated with acute and chronic antibody-mediated rejection, transplant glomerulopathy and…
2020 American Transplant Congress
Machine Learning to Predict Deceased Donor Kidney Biopsy Results
C. Martinez, A. Placona
United Network for Organ Sharing, Richmond, VA
*Purpose: Despite inconclusive evidence that kidney biopsy findings are associated with graft outcomes, biopsies are often cited as a key factor on whether to accept…
2020 American Transplant Congress
Do Higher Remuzzi Scores Make Good Kidneys Bad? Examining Histologic Criteria within the Framework of Single Kidney Transplantation
V. Fleetwood¹, C. Kensinger², C. Papageorge¹, D. Aufhauser¹, P. Pasha¹, G. Leverson³, B. Welch¹, D. Foley¹
¹Department of Transplantation, University of Wisconsin, Madison, WI, ²Department of Transplantation, Piedmont Transplant Center, Atlanta, GA, ³Department of Statistics, University of Wisconsin, Madison, WI
*Purpose: The Remuzzi score (RS), a histologic tool to assess chronic allograft damage, can guide allocation to single (SKT) or dual (DKT) kidney implantation. RS…
2020 American Transplant Congress
Standardization of Pre-Transplant Cardiac Testing in Kidney Transplant Recipients is Associated with Lower Post-Transplant Cardiac Events
I. Genev¹, A. Desai², R. Garcia-Roca³, S. Shah⁴, J. Lopez⁴, V. Mathew⁴, J. Yoo¹, S. Akkina¹
¹Department of Medicine, Loyola University Medical Center, Maywood, IL, ²Department of Medicine, Division of Transplant Nephrology, Loyola University Medical Center, Maywood, IL, ³Department of Surgery, Loyola University Medical Center, Maywood, IL, ⁴Department of Medicine, Division of Cardiology, Loyola University Medical Center, Maywood, IL
*Purpose: Cardiovascular disease is the leading cause of mortality after kidney transplantation and optimal approaches to pre-transplant cardiac testing are not well defined. We applied…
2020 American Transplant Congress
Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients is Associated with Increased Risk of Urinary Tract Infections and Pneumonia
E. Joachim, S. Parajuli, K. Swanson, F. Aziz, N. Garg, M. Mohamed, D. Mandelbrot, A. Djamali
University of Wisconsin, Madison, WI
*Purpose: Infections are a common cause of morbidity and mortality after kidney transplantation. Chronic active antibody mediated rejection (cABMR) is a leading cause of kidney…
2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Mild Hypertension
Z. Arabi¹, E. Elhassan¹, A. Altheaby¹, A. Hamad², S. Kaysi³
¹KAMC, Riyadh, Saudi Arabia, ²The Regional Medical Center, Orangeburg, SC, ³CHR Orleans, Orleans, France
*Purpose: There is variability among transplant centers in the acceptance of living donor candidates with well-controlled hypertension. Increased gestational hypertension and preeclampsia are more common…
2020 American Transplant Congress
Epidemiology of Cannabis Use and Associated Outcomes among Kidney Transplant Recipients a Meta Analysis
P. Vaitla¹, C. Thongprayoon², F. Cabeza Rivera¹, F. Koller¹, P. Matemavi¹, S. Kanduri¹, R. Marathi³, W. Cheungpasitporn¹
¹Nephrology, University of Mississippi, Jackson, MS, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Internal Medicine, University of Mississippi, Jackson, MS
*Purpose: Cannabis is the most commonly used recreational drug in the United States and transplant acceptability for cannabis using candidates varies among transplant centers. In…
2020 American Transplant Congress
A Simple Scoring System for Risk Stratification in Liver Transplantation after Donor Liver Biopsy
J. A. Steggerda, M. B. Bloom, K. Mahendraraj, T. Ramos, T. Todo, T. V. Brennan, N. N. Nissen, A. S. Klein, I. K. Kim
Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA
*Purpose: Macrosteatosis (MaS) identified on donor liver biopsy (DLBx) influences organ utilization but alone is not predictive of outcomes following liver transplantation (LT). Here we…
2020 American Transplant Congress
Stanford Integrated Psychosocial Assessment for Transplant Predicts Immunosuppression Non-Adherence after Liver Transplantation
S. Deutsch-Link¹, E. Weinberg², M. McDougal³, L. Jones⁴, T. Bitterman², M. Serper²
¹Medicine, University of Pennsylvania, Philadelphia, PA, ²Gastroenterology & Hepatology, University of Pennsylvania, Philadelphia, PA, ³Drexel University, Philadelphia, PA, ⁴PCOM, Philadelphia, PA
*Purpose: Patients with end-stage liver disease presenting for liver transplant (LT) evaluation have a high burden of psychosocial comorbidities. The Stanford Integrated Psychosocial Assessment for…
2020 American Transplant Congress
Risk Factors Associated with Hepatic Artery Thrombosis in the Modern Era
M. Krach, A. Kernodle, P. Chiang, D. Segev, A. Massie, J. Garonzik-Wang
Johns Hopkins, Baltimore, MD
*Purpose: Historically, hepatic artery thrombosis (HAT) has been associated with certain risk factors, such as donor age, cold ischemia time, and split grafts; it is unclear…